A phase II study of continuous infusion 5‐fluorouracil in advanced hormone refractory prostate cancer. An illinois cancer center study

Timothy M. Kuzel*, Martin S. Tallman, Daniel Shevrin, Edward Braud, Lary Kilton, Patricia Johnson, James Kozlowski, Nicholas J. Vogelzang, Richard Blough, Al B. Benson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of continuous infusion 5‐fluorouracil in advanced hormone refractory prostate cancer. An illinois cancer center study'. Together they form a unique fingerprint.

Medicine & Life Sciences